Skip to main content
PMC home page
Proceedings of the Royal Society of Medicine logoLink to Proceedings of the Royal Society of Medicine
. 1954 Feb;47(2):150–152.

Is Hepatolenticular Degeneration a Clinico-pathological Entity?

J G Greenfield
PMCID: PMC1918730  PMID: 13134198

Full text

PDF
150

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cooper A. M., Eckhardt R. D., Faloon W. W., Davidson C. S. INVESTIGATION OF THE AMINOACIDURIA IN WILSON'S DISEASE (HEPATOLENTICULAR DEGENERATION): DEMONSTRATION OF A DEFECT IN RENAL FUNCTION. J Clin Invest. 1950 Mar;29(3):265–278. doi: 10.1172/JCI102254. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. DENNY-BROWN D., PORTER H. The effect of BAL (2,3-dimercaptopropanol) on hepatolenticular degeneration (Wilson's disease). N Engl J Med. 1951 Dec 13;245(24):917–925. doi: 10.1056/NEJM195112132452401. [DOI] [PubMed] [Google Scholar]
  3. MATTHEWS W. B., MILNE M. D., BELL M. The metabolic disorder in hepato-lenticular degeneration. Q J Med. 1952 Oct;21(84):425–446. [PubMed] [Google Scholar]

Articles from Proceedings of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES